Alyeska Investment Group, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 46 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$1,515,000
+1.9%
150,0000.0%0.02%
-5.9%
Q3 2022$1,487,000
+1.2%
150,0000.0%0.02%0.0%
Q2 2022$1,469,000
+0.5%
150,0000.0%0.02%
+6.2%
Q1 2022$1,461,000
+0.5%
150,0000.0%0.02%
-5.9%
Q4 2021$1,454,000
+0.2%
150,0000.0%0.02%
-5.6%
Q3 2021$1,451,000
-0.7%
150,0000.0%0.02%
+5.9%
Q2 2021$1,461,000150,0000.02%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
PERISCOPE CAPITAL INC. 843,223$8,362,0000.24%
MMCAP International Inc. SPC 250,000$2,478,0000.20%
GLAZER CAPITAL, LLC 995,474$9,855,0000.18%
Ghisallo Capital Management LLC 124,800$1,238,0000.16%
Exos TFP Holdings LLC 36,044$357,0000.16%
First Trust Capital Management L.P. 228,599$2,265,0000.11%
PICTON MAHONEY ASSET MANAGEMENT 274,995$2,727,0000.10%
KIM, LLC 200,000$1,984,0000.09%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$650,0000.08%
ANGELO GORDON & CO., L.P. 40,000$396,0000.07%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders